159 related articles for article (PubMed ID: 23066153)
21. Induction of IL-10+ CD4+ CD25+ regulatory T cells with decreased NF-κB expression during immunotherapy.
Tsai YG; Chiou YL; Chien JW; Wu HP; Lin CY
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e166-73. PubMed ID: 19682278
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
24. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.
Tesio M; Tang Y; Müdder K; Saini M; von Paleske L; Macintyre E; Pasparakis M; Waisman A; Trumpp A
J Exp Med; 2015 Apr; 212(4):525-38. PubMed ID: 25824820
[TBL] [Abstract][Full Text] [Related]
26. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
[TBL] [Abstract][Full Text] [Related]
27. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
28. The NF-kappaB signalling pathway is involved in the LPS/IL-2-induced upregulation of FoxP3 expression in human CD4+CD25high regulatory T cells.
Milkova L; Voelcker V; Forstreuter I; Sack U; Anderegg U; Simon JC; Maier-Simon C
Exp Dermatol; 2010 Jan; 19(1):29-37. PubMed ID: 19845758
[TBL] [Abstract][Full Text] [Related]
29. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
Massoumi R; Paus R
Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
[TBL] [Abstract][Full Text] [Related]
30. Regulation of natural killer T-cell development by deubiquitinase CYLD.
Lee AJ; Zhou X; Chang M; Hunzeker J; Bonneau RH; Zhou D; Sun SC
EMBO J; 2010 May; 29(9):1600-12. PubMed ID: 20224552
[TBL] [Abstract][Full Text] [Related]
31. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Zhao GJ; Lu ZQ; Tang LM; Wu ZS; Wang DW; Zheng JY; Qiu QM
Int Immunopharmacol; 2012 Sep; 14(1):99-106. PubMed ID: 22749847
[TBL] [Abstract][Full Text] [Related]
33. Cylindromatosis (Cyld) gene mutation in T cells promotes the development of an IL-9-dependent allergic phenotype in experimental asthma.
Reuter S; Maxeiner J; Meyer-Martin H; Michel A; Baars P; Bopp T; Waisman A; Reissig S; Wehler TC; Schild H; Taube C; Stassen M; Becker M
Cell Immunol; 2016 Oct; 308():27-34. PubMed ID: 27372382
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.
Lim JH; Stirling B; Derry J; Koga T; Jono H; Woo CH; Xu H; Bourne P; Ha UH; Ishinaga H; Xu H; Andalibi A; Feng XH; Zhu H; Huang Y; Zhang W; Weng X; Yan C; Yin Z; Briles DE; Davis RJ; Flavell RA; Li JD
Immunity; 2007 Aug; 27(2):349-60. PubMed ID: 17723219
[TBL] [Abstract][Full Text] [Related]
35. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
de Araújo FF; Corrêa-Oliveira R; Rocha MO; Chaves AT; Fiuza JA; Fares RC; Ferreira KS; Nunes MC; Keesen TS; Damasio MP; Teixeira-Carvalho A; Gomes JA
Immunobiology; 2012 Aug; 217(8):768-77. PubMed ID: 22672991
[TBL] [Abstract][Full Text] [Related]
36. CYLD: a multifunctional deubiquitinase.
Glittenberg M; Ligoxygakis P
Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
38. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
39. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
Soper DM; Kasprowicz DJ; Ziegler SF
Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
[TBL] [Abstract][Full Text] [Related]
40. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
